about
A Software Tool for Estimation of Burden of Infectious Diseases in Europe Using Incidence-Based Disability Adjusted Life YearsBreaking the matching in nested case-control data offered several advantages for risk estimation.Estimating the annual burden of tick-borne encephalitis to inform vaccination policy, Slovenia, 2009 to 2013Effects of an ageing population and the replacement of immune birth cohorts on the burden of hepatitis A in the Netherlands.Review of disability weight studies: comparison of methodological choices and valuesUse of DALYs in economic analyses on interventions for infectious diseases: a systematic reviewTime-dependent risk of developing distant metastasis in breast cancer patients according to treatment, age and tumour characteristicsImpact of measles national vaccination coverage on burden of measles across 29 Member States of the European Union and European Economic Area, 2006-2011.Risk of hospitalisation and death due to bone fractures after breast cancer: a registry-based cohort study.Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis.Disability weights for infectious diseases in four European countries: comparison between countries and across respondent characteristics.[The evaluation process of public health action: the challenge of epidemiology].[Risk management in health care systems: the new legislative orientations in medical civil responsibility]Prognosis of Patients With Breast Cancer: Causes of Death and Effects of Time Since Diagnosis, Age, and Tumor Characteristics[Survey of the Council of Residents of the Italian Society of Hygiene (SItI) on the smoking habits of physicians training in Hygiene and Preventive Medicine.].Age at first intercourse and HPV immunizationThird Italian national survey on knowledge, attitudes, and sexual behaviour in relation to HIV/AIDS risk and the role of health education campaignsAssessment of the first HPV vaccination campaign in two northern Italian health districts
P50
Q29247957-DBE5DB24-317B-483C-B1E4-214AE65DF4B4Q31147191-367C73EC-D899-47E0-A393-C17963D3B4C7Q33601655-EF8B4C16-8F99-46D6-B14F-458C40BE6BECQ34622848-05B20765-F142-404F-9E8B-0F06CB76A723Q35653593-703C2AB7-3564-47C5-80F4-7D427890ADBCQ35686520-AFF97F45-0828-426E-A264-C3D168595EA2Q37632189-C18A2828-93CB-4D79-8D4F-93BF6AD89508Q38422221-F689E0D5-42F4-4D41-BC02-6FFABE15C915Q40554954-83FF0C98-9BF1-4B24-A223-A811A59E2BE5Q40721030-2154DC22-543F-4968-9631-E8584B980FD8Q41987030-DA0051D4-CB98-4D35-B837-BBC666F3CC47Q44558109-1F34ADE2-0333-4E70-AD0C-86528298B9B4Q56902881-79B9D6C9-6026-4550-9064-D7115420916FQ57568345-CBCCE6BF-BE0F-48BB-936E-0CE3901C6EA6Q79501292-95225119-F127-4F7E-8FE5-720EB842871BQ80828562-71720D96-7E78-4C80-BD1A-5F654F44477AQ82766300-92420959-71FD-495D-A51C-A0E6905F0E53Q83894139-3E7847F0-BCCC-45E8-9590-B49C36487D0F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
E Colzani
@ast
E Colzani
@en
E Colzani
@es
E Colzani
@nl
type
label
E Colzani
@ast
E Colzani
@en
E Colzani
@es
E Colzani
@nl
prefLabel
E Colzani
@ast
E Colzani
@en
E Colzani
@es
E Colzani
@nl
P108
P106
P1153
23476360100
P31
P496
0000-0001-8105-5027